ÖZKAN, M. 2012. The safety and efficacy of erlotinib in previously treated advanced non-small-cell lung cancer:Multicenter experience. 1. Nema Congress , (İstanbul, Turkey).

ÖZKAN, M., (2012). The safety and efficacy of erlotinib in previously treated advanced non-small-cell lung cancer:Multicenter experience . 1. Nema Congress, İstanbul, Turkey

ÖZKAN, METİN. "The safety and efficacy of erlotinib in previously treated advanced non-small-cell lung cancer:Multicenter experience," 1. Nema Congress, İstanbul, Turkey, 2012

ÖZKAN, METİN. "The safety and efficacy of erlotinib in previously treated advanced non-small-cell lung cancer:Multicenter experience." 1. Nema Congress , İstanbul, Turkey, 2012

ÖZKAN, M. (2012) . "The safety and efficacy of erlotinib in previously treated advanced non-small-cell lung cancer:Multicenter experience." 1. Nema Congress , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={METİN ÖZKAN}, title={The safety and efficacy of erlotinib in previously treated advanced non-small-cell lung cancer:Multicenter experience}, congress name={1. Nema Congress}, city={İstanbul}, country={Turkey}, year={2012}}